We are live on ! Find out more
CCM

Chicago Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 76.54%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+76.54%
3 Year Est. Return
+294.65%
5 Year Est. Return
+1,991.46%
10 Year Est. Return
+177,846.73%
AUM
$121M
AUM Growth
-$26.2M
Cap. Flow
-$44.3M
Cap. Flow %
-36.69%
Top 10 Hldgs %
58.76%
Holding
43
New
8
Increased
3
Reduced
–
Closed
14

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$11M
2
ACLX
Arcellx
ACLX
+$8.2M
3
TERN
Terns Pharmaceuticals
TERN
+$5.31M
4
APLS
Apellis Pharmaceuticals
APLS
+$4.09M
5
FOLD
Amicus Therapeutics
FOLD
+$3.81M

Top Sells

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$8.17M
2
EXAS
Exact Sciences
EXAS
+$6.56M
3
CFLT
Confluent
CFLT
+$5.34M
4
ATXS
Astria Therapeutics
ATXS
+$5.24M
5
HOLX
Hologic
HOLX
+$4.78M

Sector Composition

Rank Sector Weight
1 Healthcare 21.81%
2 Financials 9.33%
3 Industrials 7.8%
4 Communication Services 0.25%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLS
1
DELISTED
Chart Industries
GTLS
$8.27M 6.85%
+53,000
New +$11M
JHG
2
DELISTED
Janus Henderson
JHG
$8.22M 6.81%
213,000
+38,000
+22% +$1.88M
ACLX
3
DELISTED
Arcellx
ACLX
$8.04M 6.66%
+92,951
New +$8.2M
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$7.23M 5.99%
666,000
+266,000
+67% +$3.81M
APLS
5
DELISTED
Apellis Pharmaceuticals
APLS
$5.76M 4.77%
+190,000
New +$4.09M
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
$5.14M 4.26%
+129,225
New +$5.31M
HPE.PRC
7
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.7B
$2.13M 1.77%
32,900
– –
DHIL
8
DELISTED
Diamond Hill
DHIL
$1.46M 1.21%
+11,300
New +$1.94M
BLFY
9
DELISTED
Blue Foundry Bancorp
BLFY
$1.45M 1.2%
146,012
+126,278
+640% +$1.67M
THR
10
DELISTED
Thermon Group Holdings
THR
$1.14M 0.95%
+30,069
New +$1.4M
EA icon
11
Electronic Arts
EA
$52.4B
$307K 0.25%
2,000
– –
DAWN
12
DELISTED
Day One Biopharmaceuticals
DAWN
$162K 0.13%
+10,000
New +$141K
HTBK
13
DELISTED
Heritage Commerce
HTBK
$132K 0.11%
+14,014
New +$178K
ALEX
14
DELISTED
Alexander & Baldwin
ALEX
– –
-90,000
Closed -$1.39M
ATXS
15
DELISTED
Astria Therapeutics
ATXS
– –
-530,000
Closed -$5.24M
AVDL
16
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-10,000
Closed -$163K
CDTX
17
DELISTED
Cidara Therapeutics
CDTX
– –
-49,000
Closed -$8.17M
CFLT
18
DELISTED
Confluent
CFLT
– –
-235,300
Closed -$5.34M
EXAS
19
DELISTED
Exact Sciences
EXAS
– –
-86,122
Closed -$6.56M
FSFG
20
DELISTED
First Savings Financial Group
FSFG
– –
-12,977
Closed -$312K
GIFI
21
DELISTED
Gulf Island Fabrication
GIFI
– –
-36,819
Closed -$333K
HOLX
22
DELISTED
Hologic
HOLX
– –
-85,000
Closed -$4.78M
IROQ
23
DELISTED
IF Bancorp
IROQ
– –
-38,066
Closed -$1.02M
NWFL icon
24
Norwood Financial Corp
NWFL
$355M
– –
-15,069
Closed -$407K
RNAM
25
DELISTED
Avidity Biosciences
RNAM
– –
-35,000
Closed -$1.91M
1
2

Similar funds

PC
Parrish Capital Kennesaw, Georgia $112M AUM
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
AIC
Argus Investors Counsel New York $112M AUM 25.83% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
MWP
Momentum Wealth Planning Estero, Florida $113M AUM 26.08% 1-Year Est. Return

Chicago Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Chicago Capital Management held 43 positions worth $121M, down 18% from $147M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Chicago Capital Management withdrew a net $44.3M in Q1 2026, closing 14 positions. Its most notable exit was Cidara Therapeutics, an estimated $8.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

Against the trend, Chicago Capital Management opened a new position in Chart Industries worth $8.27M.

  • Chicago Capital Management's largest Q1 2026 buy was Chart Industries: 53,000 shares worth $8.27M.
  • Chicago Capital Management added most to Amicus Therapeutics in Q1 2026, an estimated $3.81M increase.
  • Chicago Capital Management fully exited Cidara Therapeutics in Q1 2026, selling an estimated $8.17M.
  • Chicago Capital Management's ten largest holdings make up 59% of its $121M portfolio in Q1 2026.
  • Chicago Capital Management opened 8 new positions and closed 14 in Q1 2026.
  • Chicago Capital Management's portfolio value fell 18% quarter-over-quarter to $121M.

Based on Chicago Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.